Emerging therapeutic targets in nitric oxide-dependent cardiac disease

By Hare Joshua M   Champion Hunter C  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 5, 2001-10 ,pp. : 547-556

Informa Healthcare

Access to resources Recommend Favorite

Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase

By Severina I.S.   Bussygina O.G.   Pyatakova N.V.   Khropov Y.V.   Krasnoperov R.A.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

Nitric oxide-dependent and -independent modulation of sympathetic vasoconstriction in the human saphenous vein

By Fabi F.   Argiolas L.   Chiavarelli M.   Del Basso P.  

European Journal of Pharmacology, Vol. 309, Iss. 1, 1996-08 ,pp. : 41-50

Elsevier

Access to resources Recommend Favorite

Inhibitory Effect of a Fullerene Derivative, Monomalonic Acid C 60 , on Nitric Oxide-Dependent Relaxation of Aortic Smooth Muscle

By Satoh M.   Matsuo K.   Kiriya H.   Mashino T.   Hirobe M.   Takayanagi I.  

General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite

Inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase by the antimalarial drug, artemisinin

By Severina I.S.   Pyatakova N.V.   Bussygina O.G.   Mikhailitsyn F.S.   Khropov Y.V.  

European Journal of Pharmacology, Vol. 438, Iss. 1, 2002-03 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite